Method for treating ocular hypertension

Details for Australian Patent Application No. 2002346562 (hide)

Owner MERCK AND CO., INC. MERCK FROSST CANADA AND CO.

Inventors Slipetz, Deborah M; Metters, Kathleen M; Billot, Xavier; Young, Robert N; Ogidigben, Miller J

Agent Spruson & Ferguson

Pub. Number AU-A-2002346562

PCT Number PCT/US02/38040

PCT Pub. Number WO2003/047513

Priority 60/400,504 02.08.02 US; 60/338,117 03.12.01 US

Filing date 27 November 2002

Wipo publication date 17 June 2003

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 60/400,504 02.08.02 US; 60/338,117 03.12.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002346562

16 March 2006 Assignment before Grant

  Merck & Co., Inc.; Merck Frosst Canada & Co. The application has been assigned to Merck & Co., Inc.; Merck Frosst Canada Ltd. Assignments before Grant, Section 113

6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346563-HIGH SURFACE AREA CARBON COMPOSITES

2002346561-EP4 receptor agonist, compositions and methods thereof